Back to Search
ABBY L'HEUREUX, M.D.
M.D.
Family Medicine Physician
NPI: 1851705941IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
RT-2694(NH)18440(NH)
Education
OTHER
Class of 2014
Research & Publications (8)
Lessons from RACs: improvements to ensure maximum payments.
PMID 19526823·Healthc Financ Manage·2009
8-other
Discovery and preclinical studies of 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737), an in vivo active potent VEGFR-2 inhibitor.
PMID 18395443·Bioorg Med Chem Lett·2008
7-preclinical
(S,E)-N-[1-(3-heteroarylphenyl)ethyl]-3-(2-fluorophenyl)acrylamides: synthesis and KCNQ2 potassium channel opener activity.
PMID 15603955·Bioorg Med Chem Lett·2005
7-preclinical
Synthesis and structure-activity relationship of acrylamides as KCNQ2 potassium channel openers.
PMID 15139767·J Med Chem·2004
7-preclinical
Concise and efficient synthesis of 4-fluoro-1H-pyrrolo[2,3-b]pyridine.
PMID 14682755·Org Lett·2003
8-other
Pyranophane transannular diels-alder approach to (+)-chatancin: a biomimetic asymmetric total synthesis.
PMID 14682691·J Org Chem·2003
8-other
(S)-N-[1-(3-morpholin-4-ylphenyl)ethyl]- 3-phenylacrylamide: an orally bioavailable KCNQ2 opener with significant activity in a cortical spreading depression model of migraine.
PMID 12852750·J Med Chem·2003
7-preclinical
Transannular Diels-Alder studies on the asymmetric total synthesis of chatancin: the pyranophane approach.
PMID 10964353·Org Lett·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 140 QUEEN CITY AVE
MANCHESTER, NH 03103 - Phone
- (603) 622-3020
Quick Facts
- NPI
- 1851705941
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 12
- Publications
- 8
Are you this provider?
Claim Your Profile